Citation Impact
Citing Papers
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Assessment of Myocardial Viability in Patients With Chronic Coronary Artery Disease
1996
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
2019
Molecular imaging in drug development
2008 Standout
Acromegaly
2006 Standout
Echocardiographic evidence for a direct effect of GH/IGF‐I hypersecretion on cardiac mass and function in young acromegalics
1998
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
Hypertrophic cardiomyopathy and sudden death in the young: Pathologic evidence of myocardial ischemia
2000
Universal Definition of Myocardial Infarction
2007 Standout
Cardiac Effects of Slow-Release Lanreotide, a Slow-Release Somatostatin Analog, in Acromegalic Patients1
1999
Guidelines on the radical management of patients with lung cancer
2010
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
2011
The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
2000 Standout
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Is the Acromegalic Cardiomyopathy Reversible? Effect of 5-Year Normalization of Growth Hormone and Insulin-Like Growth Factor I Levels on Cardiac Performance*
2001
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Cardiac autophagy is a maladaptive response to hemodynamic stress
2007 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Technetium-99m-labeled Myocardial Perfusion Agents: Are They Better than Thallium-201?
2001
Value of FDG PET Imaging in the Management of Patients With Thyroid, Neuroendocrine, and Neural Crest Tumors
2004
Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions
2001
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
2009
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article
2002 Standout
Partial adrenalectomy in patients with multiple adrenal tumors
2001
Epidemiology of Acromegaly
1999
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
von Hippel-Lindau disease
2003 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Cardiovascular Complications in Acromegaly: Methods of Assessment
2001
Clinical Characteristics and Cardiovascular Magnetic Resonance Findings in Stress (Takotsubo) Cardiomyopathy
2011 Standout
Review of Noninvasive Imaging for Hypertrophic Cardiac Syndromes and Restrictive Physiology
2006
Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction
2008 Standout
Strategies for early detection of resectable pancreatic cancer
2014
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
2009 Standout
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study
2001
Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome
2006
Subclinical Thyroid Disease
2004 Standout
Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area
2003
Distinguishing Benign from Malignant Adrenal Masses: Multi–Detector Row CT Protocol with 10-Minute Delay
2006
The global NAFLD epidemic
2013 Standout
Neuroblastoma
2007 Standout
Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors
2001
Hypertrophic Cardiomyopathy
2002 Standout
Incidentally Discovered Adrenal Masses*
1995
Current status of ECG stress testing
1998
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
Cardiac Involvement in Acromegaly: Specific Myocardiopathy or Consequence of Systemic Hypertension?1
1997
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
2002
Defunctioning Stoma Reduces Symptomatic Anastomotic Leakage After Low Anterior Resection of the Rectum for Cancer
2007
Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
2009 Standout
Growth hormone and the heart
2001
Superiority of 6-[18F]-Fluorodopamine Positron Emission TomographyVersus[131I]-Metaiodobenzylguanidine Scintigraphy in the Localization of Metastatic Pheochromocytoma
2003
Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: A PET and MRI study
2006
Magnetic Resonance Imaging of Delayed Enhancement in Hypertrophic Cardiomyopathy
2006
NAFLD: A multisystem disease
2015 Standout
Stress cardiomyopathy: Clinical and ventriculographic characteristics in 107 North American subjects
2009
Effects of 1-Year Treatment with Octreotide on Cardiac Performance in Patients with Acromegaly
1999
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Hypertrophic Cardiomyopathy
1995
Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones
2015
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Clinical Spectrum and Outcome of Functional Extraadrenal Paraganglioma
1996
Nanomaterials for In Vivo Imaging
2017
Impact of Patient’s Age and Disease Duration on Cardiac Performance in Acromegaly: A Radionuclide Angiography Study
1999
Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging
2002
6-[ 18 F]Fluorodopamine Positron Emission Tomographic (PET) Scanning for Diagnostic Localization of Pheochromocytoma
2001
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Assessment of Myocardial Viability in Patients With Chronic Coronary Artery Disease
1996
Adverse events associated with ERCP
2016 Standout
Revised Response Criteria for Malignant Lymphoma
2007 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
2001
Correlation of Early Metastatic Response by123I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma
2003
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function.
1993
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.
1993
Comparison of fluorine‐18 fluorodeoxyglucose positron emission tomography and Ga‐67 scintigraphy in evaluation of lymphoma
2002
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Contrast Magnetic Resonance Imaging in the Assessment of Myocardial Viability in Patients With Stable Coronary Artery Disease and Left Ventricular Dysfunction
1998
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
2002
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
2001
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function
1999 Standout
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Impact of Metaiodobenzylguanidine Scintigraphy on Assessing Response of High-Risk Neuroblastoma to Dose-Intensive Induction Chemotherapy
2003
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area.
1994
Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity‐related Liver Disease
2011
Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine.
1996
Benign and Malignant Pheochromocytoma
1998
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
LAPAROSCOPIC SURGERY FOR PHEOCHROMOCYTOMA: ADRENALECTOMY, PARTIAL RESECTION, EXCISION OF PARAGANGLIOMAS
1998
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
2004
Dobutamine Echocardiography Predicts Improvement of Hypoperfused Dysfunctional Myocardium After Revascularization in Patients With Coronary Artery Disease
1995
Magnetic Resonance Imaging in Coronary Artery Disease
1995
Laparoscopic Management of Extra-Adrenal Pheochromocytoma
2004
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma
2001
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of Simone Maurea being referenced
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.
1993
FDG-PET and recurrent colorectal cancer
2003
Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischemic left ventricular dysfunction
1992
Rest-injected thallium-201 redistribution and resting technetium-99m methoxyisobutylisonitrile uptake in coronary artery disease: relation to the severity of coronary artery stenosis
1993
Comparative diagnostic evaluation with MR cholangiopancreatography, ultrasonography and CT in patients with pancreatobiliary disease
2009
Tc-99m MIBI Scintigraphy in Patients With Lung Cancer Comparison with CT and Fluorine-18 FDG PET Imaging
1997
Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions.
1999
Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans
1996
Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy
2009
Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography
1993
Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease
1994
Cardiac magnetic resonance imaging illustrating Anderson–Fabry disease progression
2010
The role of radiolabeled somatostatin analogs in adrenal imaging
1996
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours
2002
Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy
1993
Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses
2010
Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents
2009
Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
1992
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
2004
Impaired left ventricular diastolic filling in patients with acromegaly: assessment with radionuclide angiography.
1995
[Role of magnetic resonance in the study of benign and malignant pheochromocytomas. Quantitative analysis of the intensity of the resonance signal].
1993
Reverse redistribution in resting thallium-201 myocardial scintigraphy in patients with coronary artery disease: relation to coronary anatomy and ventricular function.
1993
The Diagnosis of Nonfunctioning Pheochromocytoma The Role of I-123 MIBG Imaging
1995
Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease.
1995
Iodine-131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison with laboratory analysis.
1994
Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution.
1995
Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media.
2014
Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison.
1996
[Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment].
1998
[The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
1998
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
2001
AIDS and nuclear medicine.
1995